Authors' reply to Tufan and colleagues and Boucaud-Maitre.
University of Bordeaux, UMR1219, F-33000 Bordeaux, France INSERM, UMR1219, Bordeaux Population Health Research Centre, Pharmacoepidemiology team, Bordeaux, France CHU Bordeaux, Bordeaux, France.
Francesco
F
Salvo
University of Bordeaux, UMR1219, F-33000 Bordeaux, France INSERM, UMR1219, Bordeaux Population Health Research Centre, Pharmacoepidemiology team, Bordeaux, France CHU Bordeaux, Bordeaux, France CIC Bordeaux CIC1401, Bordeaux, France.
Nicholas
N
Moore
University of Bordeaux, UMR1219, F-33000 Bordeaux, France INSERM, UMR1219, Bordeaux Population Health Research Centre, Pharmacoepidemiology team, Bordeaux, France.
Mickael
M
Arnaud
CIC Bordeaux CIC1401, Bordeaux, France ADERA, Pessac, France.
Philip
P
Robinson
Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
Emanuel
E
Raschi
Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
Fabrizio
F
De Ponti
University of Bordeaux, UMR1219, F-33000 Bordeaux, France INSERM, UMR1219, Bordeaux Population Health Research Centre, Pharmacoepidemiology team, Bordeaux, France CHU Bordeaux, Bordeaux, France.
Bernard
B
Bégaud
University of Bordeaux, UMR1219, F-33000 Bordeaux, France INSERM, UMR1219, Bordeaux Population Health Research Centre, Pharmacoepidemiology team, Bordeaux, France CHU Bordeaux, Bordeaux, France.
Antoine
A
Pariente
D000368:Aged; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D054873:Dipeptidyl-Peptidase IV Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D004359:Drug Therapy, Combination; D006801:Humans; D007003:Hypoglycemia / Q000139:chemically induced / Q000517:prevention & control; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000009:adverse effects; D015201:Meta-Analysis as Topic; D018579:Patient Selection; D012107:Research Design; D020379:Risk Adjustment; D013453:Sulfonylurea Compounds / Q000008:administration & dosage / Q000009:adverse effects
D054873:Dipeptidyl-Peptidase IV Inhibitors; D007004:Hypoglycemic Agents; D013453:Sulfonylurea Compounds